---
$id: https://graph.org.ai/products/commodity/51131726
$type: Product
source: UNSPSC
code: "51131726"
title: "Gantofiban"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gantofiban

**UNSPSC Code**: 51131726
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thrombolytic agent with the molecular formula C21H29N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MRG9KH7HF6, chemically known as 4-(((5r)-3-(p-(carboxyamidino)phenyl)-2-oxo-5-oxazolidinyl)methyl)-1-piperazineacetic acid, 1-ethyl methyl ester. but generally known as gantofiban, which bears US NIH Compound Identifier 9578736. The term GANTOFIBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule gantofiban under HS 29349990 and SITC 51579. As of Q4 2014, GANTOFIBAN remains the US FDA Preferred Term for this commodity. Gantofiban bears US NLM identifiers UMLS ID C1120900 and NCI Concept Code C73227. SMILES: CCCOC(=O)CN1CCN(CC1)CC2CN(C(=O)O2)C3=CC=C(C=C3)C(=NC(=O)O)N.

